Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
33.84
-1.20 (-3.42%)
Mar 9, 2026, 3:56 PM EDT - Market open
Tyra Biosciences Market Cap
Tyra Biosciences has a market cap or net worth of $1.82 billion as of March 9, 2026. Its market cap has increased by 171.15% in one year.
Market Cap
1.82B
Enterprise Value
1.55B
1-Year Change
171.15%
Ranking
Category
Stock Price
$33.84
Market Cap Chart
Since the IPO on September 15, 2021, Tyra Biosciences's market cap has increased from $654.64M to $1.82B, an increase of 178.45%. That is a compound annual growth rate of 25.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 1.89B | 34.52% |
| Dec 31, 2025 | 1.40B | 91.90% |
| Dec 31, 2024 | 731.18M | 22.61% |
| Dec 29, 2023 | 596.34M | 87.61% |
| Dec 30, 2022 | 317.87M | -44.42% |
| Dec 31, 2021 | 571.90M | -12.64% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nektar Therapeutics | 1.98B |
| Celldex Therapeutics | 1.96B |
| Syndax Pharmaceuticals | 1.95B |
| Aurinia Pharmaceuticals | 1.90B |
| Recursion Pharmaceuticals | 1.83B |
| Veradermics | 1.81B |
| Palvella Therapeutics | 1.81B |
| Zymeworks | 1.78B |